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Mechanisms of insulin resistance related to
white, beige, and brown adipocytes
Michael P. Czech 1
ABSTRACT
Background: The diminished glucose lowering effect of insulin in obesity, called “insulin resistance,” is associated with glucose intolerance,
type 2 diabetes, and other serious maladies. Many publications on this topic have suggested numerous hypotheses on the molecular and cellular
disruptions that contribute to the syndrome. However, significant uncertainty remains on the mechanisms of its initiation and long-term
maintenance.
Scope of review: To simplify insulin resistance analysis, this review focuses on the unifying concept that adipose tissue is a central regulator of
systemic glucose homeostasis by controlling liver and skeletal muscle metabolism. Key aspects of adipose function related to insulin resistance
reviewed are: 1) the modes by which specific adipose tissues control hepatic glucose output and systemic glucose disposal, 2) recently acquired
understanding of the underlying mechanisms of these modes of regulation, and 3) the steps in these pathways adversely affected by obesity that
cause insulin resistance.
Major conclusions: Adipocyte heterogeneity is required to mediate the multiple pathways that control systemic glucose tolerance. White
adipocytes specialize in sequestering triglycerides away from the liver, muscle, and other tissues to limit toxicity. In contrast, brown/beige
adipocytes are very active in directly taking up glucose in response to b adrenergic signaling and insulin and enhancing energy expenditure.
Nonetheless, white, beige, and brown adipocytes all share the common feature of secreting factors and possibly exosomes that act on distant
tissues to control glucose homeostasis. Obesity exerts deleterious effects on each of these adipocyte functions to cause insulin resistance.
 2020 The Author. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Adipokines; Adipose tissues; Adrenergic receptors; Bioactive lipids; Glucose tolerance; Lipogenesis; Signaling; Thermogenesis;
Uncoupling protein
1. INTRODUCTION
Insulin is a vital hormone, as both its absence and excess are lethal
in humans. Insulin has even been exploited as a murder weapon in
notorious crime cases [1]. Its introduction into clinical usage in the
early 1920s was designed to replace the insulin lacking in type 1
diabetes, but its use soon revealed confounding paradoxes that
engage the field to this day. For example, higher carbohydrate
consumption by those with diabetes often unexpectedly decreases
the required doses of insulin rather than increasing them. Glucose
tolerance tests in humans also showed marked sensitivity to feeding
vs fasting, and normal human subjects fed high-fat diets became
extraordinarily glucose intolerant [2]. Himsworth et al. subsequently
found that insulin was surprisingly ineffective in disposing a glucose
load in obese subjects with diabetes, and by 1940 they had cate-
gorized diabetes as two types: “insulin sensitive” vs “insulin
insensitive” [3]. This insight explained a related paradox, discovered
in the 1960s via radioimmunoassay, that circulating insulin was
sometimes highly elevated rather than decreased in obese subjects
with mild diabetes [4]. Hyperinsulinemia associated with decreased
responsiveness to insulin may itself be one of the major drivers of
this insulin insensitive state [5,6]. Altogether, these and other find-
ings solidified a strong overall paradigm that peripheral tissue
resistance to the actions of insulin is caused by overnutrition and
obesity [7].
This impairment in systemic responses to insulin in human and rodent
obesity, as defined by its blood glucose lowering effects, reflects
decreased insulin sensitivity in one or a combination of the major
metabolic organs: liver, muscle, and adipose tissues. In the liver, in-
sulin loses its full ability to inhibit glucose output through glycogen-
olysis and gluconeogenesis, while in the muscle and adipose tissues,
insulin-stimulated glucose uptake and utilization are impaired [5,8e
10]. However, the effects of insulin on these tissues are not always
cell autonomous (Figure 1), as exemplified by insulin modulation of
hepatic metabolism secondarily through its regulation of adipocyte
fatty acid release [11,12]. Since the insulin resistant state correlates so
closely with serious maladies such as type 2 diabetes and cardio-
vascular disease in humans [13,14], it has been extensively studied for
decades. Scientists new to the field are now confronted by vast
literature on the topic, as a PubMed search quickly reveals (Table 1).
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Searching for the term “insulin resistance” yields 119,349 citations, an
overwhelming number of publications. In 2018 alone, more than 8,000
publications referred to insulin resistance. Moreover, there is a
multitude of cellular pathways that have been hypothesized to mediate
insulin resistance in obesity, each with extensive support from hun-
dreds or even thousands of publications (Table 1). While there have
been highly significant improvements in therapies for type 2 diabetes,
it could be argued that there has been no breakthrough with the
equivalent impact on the discovery of insulin itself in 1921. Meanwhile,
the prevalence of diabetes in the US has since increased from
approximately 1% to nearly 10% of the population. Thus, it is not
difficult to understand why insulin resistance and type 2 diabetes can
be daunting for investigators new to the field.
2. ADIPOSE TISSUE AS A CENTRAL NODE IN SYSTEMIC
METABOLISM
Can a central theme consolidate the vast amount of research on insulin
resistance into a useful framework to guide future strategies? One
such major consilience that has emerged over the last two decades is
the concept that adipose tissues are major regulators of metabolism
and cell signaling in the liver and skeletal muscle [15e17]. Accord-
ingly, adipose tissue dysfunctions under high-fat diet (HFD) or obese
conditions are thought to mediate disruptive signals to other metabolic
tissues through the circulation [11,12], central nervous system [18], or
potentially release of exosomes [17]. This is perhaps unsurprising as
adipose tissues are dramatically affected by obesity and significantly
expand in mass over the lean condition. Three general mechanisms
have been hypothesized to mediate such adipose tissue control over
other tissues and systemic glucose homeostasis (Figure 1): 1) lipid
sequestration within white adipocyte depots by enhancing synthesis or
limiting lipolysis that prevents toxic lipid accumulation in the liver and
skeletal muscle [19e21] and is compromised in lipodystrophy [19], 2)
high rates of glucose and fatty acid oxidation within specialized beige
and brown adipocytes that increase energy expenditure and reduce
lipid load [22e24], and 3) secretion of bioactive factors that can target
the brain, liver, skeletal muscle, pancreatic islets, or other tissues
[15e17,25e27]. Each of these complex adipose biology pathways
have been shown to modulate whole body glucose tolerance and in-
sulin sensitivity.
The aim of this review article is to provide a broad summary of the field
and focus on key questions related to insulin resistance in one affected
organ: adipose tissue. Based on the vast literature and the broad
perspective covered herein, recent reviews are cited that cover specific
areas of investigation in a deeper fashion in addition to the selected
original papers. This overview will hopefully promote further research
to more fully answer such questions as: What specific steps in the
many pathways that control adipocyte functions are actually perturbed
in insulin resistant obesity, and how? What contribution do each of
Figure 1: Pathways by which WAT and BAT depots serve as major nodes of systemic metabolic regulation. Adipokines and batokines regulate hepatic lipogenesis and
glucose output as well as glucose uptake and disposal by muscle. Secreted factors from adipocytes can also act in a paracrine fashion to regulate other cell types within adipose
depots such as vascular cells and nerve fibers. BAT thermogenesis may contribute to systemic glucose disposal and oxidize lipids to lower systemic toxicity. WAT lipolysis in
obesity can contribute to fatty acid and glycerol overload in the liver to enhance gluconeogenesis and glucose output. WAT-derived fatty acids also contribute to skeletal muscle
insulin resistance (not shown). The combination of the actions of peptides, lipids, small RNA, and other factors from adipocytes plus the released lipolytic products (fatty acids and
glycerol) have major influences on local cell types within adipose tissue as well as on distant tissues.
Table 1 e Number of total and 2018 PubMed citations related to insulin
resistance and some of the various major cellular pathways that have been
implicated in the induction of insulin resistance in obesity. The terms
“insulin resistance” or “insulin resistance and” and each of the terms listed
in the table under “Cellular pathway” was searched on August 21, 2019.
The number of total citations are provided for each of these searches.
Cellular Pathway Total PubMed Citations 2018 PubMed Citations
Insulin Resistance 119,837 8376
Insulin Resistance and .
Protein kinase 11,449 744
Fatty Acids 10,970 668
Cytokines 9331 613
Reactive Oxygen Species 2207 199
Microbiota 1117 228
Hypoxia 852 83
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these pathways make in causing insulin resistance in adipocytes? How
do adipocyte disruptions in obesity cause whole body glucose intol-
erance? Hopefully, some central features and analytics of insulin
resistance in adipocytes will also be applicable to other tissues for a
better understanding of systemic metabolic regulation.
3. INSULIN-RESPONSIVE ADIPOSE TISSUE SUBTYPES
Based on the capabilities of adipose tissues to control systemic
metabolism, it is unsurprising that there are many subtypes of adi-
pocytes. Indeed, the heterogeneity of adipose tissue depots and the
constituent adipocytes within the depots are logically required to
execute the various paradigms of systemic metabolic control. The
cellular constituents of the many adipose tissue depots in various lo-
cations throughout the body are well known to be associated with
distinct characteristics and functional differences [28e30]. Most
notable in rodents are the contrasting energy storing capacities of
white adipose tissue (WAT) depots compared to the energy expenditure
capacities of brown adipose tissue depots (BAT). Significant differ-
ences between subcutaneous WAT depots and visceral WAT depots
have also been extensively documented, including distinct gene
expression profiles of the resident adipocytes, immune cell infiltration
patterns, and metabolic flux [31e36].
Three major classes of adipocytes in these various depots have been
extensively studied. These include white adipocytes specialized for
triglyceride storage in WAT, as opposed to beige adipocytes within
WAT and brown adipocytes in BAT that display high respiration rates
associated with uncoupling protein UCP1 within mitochondria [37e
40]. Beige adipocytes appear within certain white adipose depots
during cold exposure or even intermittent fasting in mice [25,39e44]
and in certain adipose depots in humans, especially in regions that are
highly vascularized in the neck and thoracic areas [41,45e50]. Beige
adipocytes appear to differ from brown adipocytes not only in their
respective location in WAT vs BAT depots, but also in their develop-
mental program, and their responsiveness to adrenergic signaling with
respect to mitochondrial regulation and UCP1 expression. Beige cells
appear to display a more rapid response and reversion to cold expo-
sure and withdrawal, respectively, whereas brown adipocytes express
constitutively high levels of UCP1 and lose this expression over a longer
time period during exposure to thermoneutrality [41]. Both beige and
brown adipocytes appear to contribute to weight gain and enhanced
glucose tolerance in rodents [22,42e44,51] and humans [52], either
through their ability to enhance energy expenditure or secrete factors
beneficial to the liver, skeletal muscle, and other tissues, or via both
mechanisms.
Recent work has highlighted further degrees of adipocyte heteroge-
neity within WAT and BAT, and discoveries along these lines are
currently rapidly increasing with the advent of single cell and single
nuclei RNA sequencing technology [53e56] as well as single pro-
genitor cell cloning [57]. These findings include substantial hetero-
geneity of precursor adipocyte progenitor cells [54,55,57e60] and
heterogeneity of fully differentiated adipocytes comparing distinct
adipose depots [28,29,61] or even within the same depot [62e65].
These studies have revealed a multitude of other cell types that are
also present within adipose depots, including endothelial cells and
many types of immune cells. Single cell sequencing has also
demonstrated a mesenchymal progenitor cell hierarchy in adipose
tissue in both mice and humans [66]. Importantly, studies show that
adipocyte progenitor cells can proliferate in response to HFD conditions
that elicit insulin resistance, and that progenitor proliferation is
dependent on adipose depot, dietary lipids, microenvironment, and
hormones [67e71]. A stromal cell population has been identified that
inhibits adipocyte progenitor proliferation [72]. Signature gene
expression profiles in clonal human adipocyte progenitor lines also
reveal beige vs white adipocyte fates [57,73]. This area of research is
expanding rapidly and will be required to define the detailed dynamics
of white and beige adipose tissue depot remodeling under various
physiological conditions.
Significant differences in the rates of lipolysis and lipid uptake in white
adipocytes derived from visceral vs subcutaneous depots have been
well documented and reviewed [29,31]. White adipocyte heterogeneity
within the same depot has been observed in both gene expression and
insulin sensitivity under normal conditions [62] and in b-adrenergic
receptor expression on the cell surface [63]. By isolating preadipocyte
clonal lines from human subcutaneous WAT, several subtypes of such
precursors and the derived white adipocytes can be defined by distinct
gene expression profiles [57]. These included differential expression
levels of leptin vs adiponectin in white adipocyte subtypes in addition to
the identification of a human thermogenic adipocyte subtype [57]. This
approach has led to improved adipose implantation techniques [74].
Single nuclei [56] and single cell RNA [54,55] sequencing methods
have led to the identification of multiple white adipocyte subtypes and
brown adipocyte subtypes with differing thermogenic potential [75]. A
subtype of beige adipocytes with high glycolytic activity independent of
adrenergic stimulation has also been identified [76]. Altogether, these
new findings and more to come will complicate the understanding of
insulin resistance since the contributions of these different adipocyte
subtypes will vary considerably.
4. OBESITY-MEDIATED DISRUPTIONS OF WHITE ADIPOCYTE
LIPID METABOLISM
Adipose dysfunctions in genetic obesity and under high-fat diet (HFD)
conditions include decreasing the capacity of enlarged white adipo-
cytes to synthesize, esterify, and store triglycerides in a central lipid
droplet. These deficiencies are caused in part by the lower expression
of enzymes in lipid synthesis, fatty acid esterification, and seques-
tration, including decreased levels of lipid droplet proteins that nor-
mally protect stored triglycerides from lipolysis [reviewed in
Refs. [9,77e79]]. Obesity decreases the rates of white adipocyte
glycerol 3-phosphate formation from glycolysis due to decreased
glucose uptake and a decreased “glyceroneogenesis” pathway (py-
ruvate conversion to glycerol 3-phosphate) in response to the down-
regulation of adipocyte phosphoenol phosphate carboxykinase [80].
Obesity also modulates diacylglycerol acyl transferase (DGAT) en-
zymes, especially DGAT in subcutaneous adipose tissue [81], which
catalyze esterification of diacylglycerol with fatty acyl CoA in the final
step of triglyceride synthesis [82]. Thus, this fatty acid esterification
rate to form and store triglyceride in some depots of white adipocytes
is likely reduced in obesity as the overall lipid metabolism enzymes are
downregulated in obese, glucose-intolerant subjects (Figure 2,
pathway 4) [83]. Importantly, adipose-specific DGAT1 knockout mice
show reduced systemic glucose intolerance and apparent lipotoxicity
due in part to elicitation of a stress response and inflammation [84,85].
The mechanisms that downregulate overall adipocyte lipid synthesis
and lipid storage proteins in obesity are incompletely understood, but
likely include attenuation of the activities of transcription factors such
as CHREBPa/CHREBPb [86e88] and PPARg [9,89,90] that regulate
the expression of these genes (Figure 2, pathway 5).
Insulin signaling to metabolism in sensitive tissues is largely triggered
by insulin receptor tyrosine kinase activation leading to protein kinase
Akt stimulation [91]; some of the intermediate signaling elements are
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listed in Table 2. Downregulation of adipocyte lipid synthesis capacity
and lipid droplet proteins in obesity does not necessarily directly affect
the activity of insulin signaling itself, but is associated with insulin
resistance in other tissues and decreases whole body glucose toler-
ance [9]. For example, deletion of lipid droplet protein Fsp27 in adi-
pocytes in conditional obese mouse knockout models causes
decreased adipocyte fat deposition, lipodystrophy, systemic glucose
intolerance, and insulin resistance [92]. However, the latter is due to
increased hepatic insulin resistance associated with steatosis and
increased liver glucose output, while adipose depots remain insulin
responsive with respect to enhanced protein kinase Akt phosphory-
lation and actually display decreased inflammation [92]. These results
support the hypothesis that the decreased ability of adipose depots to
sequester fat away from the liver in Fsp27-deficient adipocytes is the
cause of hepatic insulin resistance and fat accumulation. Mechanis-
tically, recent results indicate that the link between excess fat entry
into the liver and insulin resistance is the buildup of mitochondrial
acetyl CoA that can activate a rate limiting enzyme (pyruvate carbox-
ylase) in the gluconeogenesis pathway [11,12]. This apparently in-
creases hepatic glucose production to an extent that cannot be
inhibited by direct insulin action on hepatocytes.
5. OBESITY-MEDIATED DISRUPTION OF “ADIPOKINES” AND
“BATOKINES”
A second general mode whereby adipocyte disruptions caused by
obesity can mediate systemic insulin resistance, even while the adi-
pocytes themselves are not insulin resistant, relates to secretion of
bioactive factors [25e27]. Both white adipocytes and brown/beige
adipocytes secrete such factors, called “adipokines,” and some are
more selectively secreted by BAT, called “batokines” (Figure 1). The
canonical white adipocyte adipokine is leptin, which regulates many
physiological parameters including appetite and energy expenditure
[93,94]. Adipocytes secrete many such factors that do not directly
modulate adipocyte insulin sensitivity in a cell autonomous manner but
rather act as hormones to effect nearby or distant tissues, and in some
cases their production is suppressed in obesity [15e17,25e27]. One
example is the adipokine adiponectin, which is secreted into the cir-
culation at high concentrations and enhances overall systemic glucose
tolerance and insulin sensitivity in obese mice, as evidenced by ex-
periments with adiponectin knockout mice [95]. Another example is
neuregulin 4 (Nrg4), which is highly expressed in BAT, less so in WAT,
but not in virtually any other examined cell type within peripheral
tissues in mice [96e99]. As with adiponectin, adipose Nrg4 production
is severely downregulated in obesity in mice and humans. Nrg4 found
in the circulation seems largely derived from adipose tissues and
functions to decrease hepatic fatty acid synthesis and maintain sys-
temic insulin sensitivity [96]. Nrg4 knockout leads to severe hepatic
steatosis, exacerbation of glucose intolerance, and insulin resistance in
obese mice [96]. Transgenic Nrg4 overexpression in mice leads to
decreased liver steatosis and increased systemic insulin sensitivity and
glucose tolerance. Under hyperinsulinemic, euglycemic clamp condi-
tions, increased insulin sensitivity is readily observed in skeletal
muscle but not WAT or BAT [96]. These results represent striking
examples of adipose dysfunction in obesity driving systemic insulin
resistance through downregulation of secreted protein adipokines and
Figure 2: Sites of disrupted functions in white adipocytes due to genetic and diet-induced obesity. At least 5 major insulin-responsive pathways that affect adipocyte
metabolism are dysfunctional in obesity and are numbered in the figure. These include 1) insulin signaling elements from insulin receptor to activation of protein kinase Akt, 2) the
expression of glucose transporter GLUT4, 3) the membrane trafficking of GLUT4 that enhances its abundance on the plasma membrane in response to insulin, 4) the entry and
metabolism of glucose that is converted to fatty acids through de novo lipogenesis and through esterification of glycerol 3-phosphate with fatty acids, and 5) the regulation of
expression of many of the proteins and regulators of these pathways through the actions of transcription factors, some of which are themselves responsive to insulin action (for
example, CHREBP and FOXO1). These dysfunctions likely all contribute to adipocyte insulin resistance at some stages of acute and chronic obesity, and the degree to which each
contributes continue to be actively debated. A key question for current and future studies that is raised by these considerations is the degree to which obesity-altered metabolite
levels within adipocytes are able to signal, directly or indirectly, to the outputs at the right of the figure that regulate other cell types within adipose tissue as well as other distant
organs such as the brain, liver, muscle, and pancreatic islets.
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batokines, which act on peripheral tissues but not directly on adipo-
cytes themselves.
Recent results have identified several lipid species released from
adipocytes that may also regulate systemic glucose tolerance. Ex-
periments that demonstrate systemic effects upon knockout of genes
that drive synthesis of such lipids are particularly important in con-
firming their physiological function. One example relates to the role of
12-hydroxyeicosapentaenoic acid (12-HEPE), which is produced by
BAT in response to catecholamine during cold exposure [100].
Importantly, 12-HEPE causes increased glucose uptake into BAT and
skeletal muscle and BAT-selective gene ablation of the lipoxygenase
(12-LOX) that produces this lipid, causing glucose intolerance in mice
[100]. Moreover, 12-LOX KO mice were less able to adapt to the cold.
Obesity in humans markedly decreases circulating 12-HEPE levels,
and insulin sensitivity varies inversely with levels of this lipokine. The
related lipokine, 12,13-dihydroxy-9Z-octadecenoic acid (12,13-
diHOME), was found to be increased in the circulation of mice and
humans during exercise [101]. It was shown that the main source of
this lipokine is also BAT in mice, and that its action on skeletal muscle
increased fatty acid uptake and oxidation.
These findings exemplify the overall conclusion from many studies that
obesity can downregulate both protein and lipid factors secreted
specifically by adipocytes that normally act to maintain normal sys-
temic insulin sensitivity in the liver and skeletal muscle (Figure 1),
thereby contributing to systemic glucose intolerance and insulin
resistance. Many recent publications have summarized this vast
literature on adipokines and batokines and their possible roles in
regulating peripheral glucose tolerance [15e17,24e27,102].
6. ADIPOCYTE INSULIN SENSITIVITY INFLUENCES SYSTEMIC
GLUCOSE TOLERANCE
White, beige, and brown adipocytes are all responsive to insulin, and
the most widely studied insulin-stimulated anabolic pathways are
glucose uptake and esterification, transcription of selected mRNAs,
protein synthesis, and de novo lipogenesis. Conversely, lipolytic activity
in adipocytes is strongly inhibited by insulin, and the combined effects
of these insulin-responsive processes is lipid accumulation in large
unilocular (white adipocytes) or multilocular (beige and brown adipo-
cytes) lipid droplets. While systemic insulin resistance is mostly
studied in terms of glucose dynamics [103], basal lipolysis and the
ability of insulin to lower serum free fatty acids and glycerol through
the inhibition of lipolysis in white adipocytes may also be attenuated to
some extent in obesity [104e106]. This appears to occur in part
through phosphorylation of the b-adrenergic receptor by enhanced
ERK MAP kinase in obesity [107]. This effect of insulin on adipocyte
lipolysis is thought to be significant in systemic insulin sensitivity and
glucose intolerance because circulating fatty acids that are taken up by
the liver stimulate hepatic gluconeogenesis [11,12]. Glycerol released
from adipocyte lipolysis also enhances hepatic glucose output as a
substrate of gluconeogenesis.
Thus, insulin sensitivity of liver glucose output involves direct action on
hepatocytes through signaling to the protein kinase Akt and indirect
action through insulin action on adipocytes to suppress fatty acid and
glycerol release. Mechanistically, the inhibitory effect of insulin on
lipolysis is partially mediated through the central nervous system [108]
in conjunction with cell autonomous mechanisms [109]. It should be
also be noted that insulin stimulation of glucose uptake and glycolysis
in adipocytes generates glycerol 3-phosphate for esterification of fatty
acids, providing a third mechanism for decreasing the release of fatty
acids from adipose tissue. Furthermore, circulating fatty acids are also
thought to generate insulin resistance in skeletal muscle through cell
autonomous effects on insulin-stimulated glucose uptake and utiliza-
tion [8,9]. Taken together, it is clear that insulin-sensitive white
adipocyte glucose uptake and lipolysis pathways are linked to sec-
ondary effects on liver and muscle insulin responsiveness through
released fatty acids and other factors in the context of overnutrition.
These considerations suggest that white adipocyte insulin sensitivity is
itself important for maintaining whole body glucose homeostasis
through indirectly regulating liver or muscle. Accordingly, many labo-
ratories have directly tested the hypothesis that disrupting or
Table 2 e Adipocyte-selective gene deletions of components involved
in insulin stimulation of glucose utilization and inhibition of lipolysis
result in parallel effects on whole body insulin sensitivity or glucose
tolerance (GTT). Experimental manipulation of the listed insulin signaling
elements or targets specifically in all adipocyte types causes similar effects
on systemic glucose tolerance. Thus, gene knockout of elements selectively
in adipocytes that drive the pathway of insulin stimulation of glucose uptake
and esterification to triglyceride (for example, insulin receptor, Akt) also
attenuate whole body insulin sensitivity and enhance obesity-induced
insulin resistance. Conversely, adipose-selective deletions of genes that
enhance insulin signaling in adipocytes (for example, p85 insufficiency that
stimulates PI 3K or PIP3 phosphatase PTEN) cause increased systemic
insulin sensitivity and attenuate insulin resistance in obesity. In concert with
these results, adipose-selective deletion of genes encoding downstream
targets of insulin signaling such as glucose transporter GLUT4 or fatty acid
esterification enzyme DGAT1 diminish whole body glucose tolerance and
enhance insulin resistance. Adipose-selective gene deletion of ATGL mimics
the action of insulin to decrease adipocyte lipolysis, which enhances
systemic insulin sensitivity by decreasing hepatic steatosis and insulin
resistance. In contrast, when insulin signaling elements are deleted
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amplifying insulin signaling elements or the target systems of such
signaling within adipocytes modulates systemic insulin sensitivity. The
results of such experiments are summarized in Table 2 and over-
whelmingly support this concept. For example, gene deletion of the
insulin receptor from all adipocyte types leads to lipodystrophy, liver
steatosis, and insulin resistance in the liver and skeletal muscle [110].
Insulin receptor knockout selectively in UCP-1 positive brown and
beige adipocytes causes systemic glucose intolerance due to deficits in
insulin secretion from beta cells in the pancreas [111]. Similarly,
adipose-specific deletion of signaling elements downstream of the
insulin receptor such as protein kinase Akt2 cause insulin resistance in
the liver and skeletal muscle and systemic glucose intolerance on a
high-fat diet [112]. Attenuating adipocyte mTORC1 activity, a target of
insulin-sensitive Akt2 signaling, compromises lipid accumulation in the
adipocytes and decreases systemic insulin sensitivity in conjunction
with lipodystrophy [113]. Adipose-selective knockout of insulin-
regulated glucose transporter GLUT4 [114] or downstream enzyme
DGAT1 [84,85] that catalyzes esterification of glycerol 3-phosphate
and fatty acid into triglycerides also lead to systemic glucose
intolerance.
Conversely, increasing adipocyte insulin signaling by partial depletion
of the negative regulator p85 subunit of PI 3K [115], PIP3 phosphatase
PTEN [116], or overexpressing insulin-sensitive GLUT4 [114] is suffi-
cient to enhance systemic insulin sensitivity under obese conditions in
mice. Importantly, mimicking insulin’s inhibitory action on lipolysis in
adipocytes by knockout of ATGL lipase mimics insulin’s suppression of
hepatic gluconeogenesis, enhancing systemic glucose tolerance
[11,117]. Taken together (Table 2), these results from various labo-
ratories solidify the conclusion that insulin sensitivity of white adipo-
cytes induces profound long-distance regulation of the liver and
skeletal muscle to modulate systemic glucose and fatty acid homeo-
stasis under obese conditions.
While experimental perturbations of insulin sensitivity of white adipo-
cytes cause concordant changes in systemic insulin sensitivity in
obesity, the relationship to systemic glucose tolerance is more
complicated with respect to brown/beige adipocytes. Insulin receptor
knockout in brown/beige adipocytes does not cause systemic insulin
resistance as does insulin receptor deletion in both white and brown
adipocyte types [111]. Furthermore, deletion of the mTORC2 complex
subunit RICTOR through UCP1 promoter-driven Cre expression in
RICTOR floxed mice, which blocks insulin-stimulated Akt2 activation in
BAT and beige adipocytes, actually increases systemic glucose toler-
ance [118]. This appears to be due to enhanced adipocyte catabolism
through unknown mechanisms. Nonetheless, insulin-stimulated fuel
utilization may be dominant in BAT during the postprandial period
[119,120]. BAT lipolysis does not appear necessary for thermogenesis
in vivo, as WAT can supply fatty acids for fuel if BAT lipolysis is dis-
rupted [121]. However, such disruption causes browning of WAT along
with increased glucose tolerance, complicating interpretations. Insulin
signaling can suppress the process of “browning” of white adipocytes,
as experimentally induced hypoinsulinemia causes upregulation of
UCP1 [122]. Collectively, these data reveal the complicated mecha-
nisms whereby brown/beige adipocytes are interconnected with sys-
temic glucose homeostasis and the importance of specific
environmental conditions in driving various phenotypes related to
brown/beige adipocyte perturbations. Nonetheless, these studies
demonstrate that cell autonomous perturbations in insulin signaling
sensitivity within white or brown/beige adipocytes translate to marked
changes in whole body metabolic dynamics.
7. WHITE ADIPOCYTE INSULIN RESISTANCE: SITES OF
DISRUPTION
7.1. Insulin signaling elements
Based on the convincing results summarized in Table 2 as previously
described, a logical therapeutic strategy for alleviating systemic in-
sulin resistance is reversing adipocyte dysfunctions in obesity,
including the diminished capacity of white adipocytes to respond to
insulin. This strategy would be enhanced by detailed knowledge of
the molecular basis of insulin signaling to metabolic targets in white,
beige, and brown adipocytes and the steps controlling white
adipocyte glucose and lipid metabolism that go awry in obesity.
Indeed, several of the aforementioned experimental gene deletions of
insulin signaling components have parallels in rare mutations that
occur in humans. Examples include the insulin receptor, its down-
stream target protein kinase Akt, and its substrate TBC1D4 [123]. In
the common forms of human obesity associated with insulin resis-
tance that are devoid of such disease mutations, there are often
deficiencies in the expression or activation of these same insulin
signaling elements (Figure 2) when measured in white adipocytes
[8,9,91,124,125]. Thus, insulin-mediated activation of Akt, the
required signaling circuit for stimulation of Glut4 translocation and
glucose uptake, is often decreased in adipocytes in obese, insulin
resistant subjects and obese rodent models of insulin resistance
[126]. Conversely, the role of insulin-sensitive Akt in regulating
lipolysis has mixed support [127e131], and the ability of obesity to
affect the cell autonomous pathway of lipolysis regulation via insulin
as opposed to the re-esterification of fatty acids may be relatively
small [103,129].
Despite this attenuation of adipocyte insulin signaling to stimulate Akt
in chronic obesity, the degree to which deficits in insulin signaling
elements, including the insulin receptor, insulin receptor substrate
proteins, PI-3K, Akt, and its glucose transport-relevant substrate
AS160/TBD1D4 actually contribute to the decreased glucose uptake
and utilization in obesity is a subject of continued debate [5,132,133].
Systemic insulin resistance occurs only a few days after the start of
high-fat feeding in mice to induce obesity, including strong deficits in
insulin stimulation of adipocyte glucose uptake and systemic glucose
intolerance [5]. However, both systemic and adipocyte insulin resis-
tance occurs in the absence of apparent decreases in Akt activation in
adipose tissue at these early time points [134,135]. Only later in the
development of obesity are such deficiencies in Akt activation
consistently observed that may contribute to insulin resistance. This
lag period prior to the attenuation of Akt regulation may be related to
the delayed occurrence of adipose inflammation upon initiating nutri-
tional overload [136], although this is variable [137]. Paracrine
signaling from immune cells within adipose tissue in obesity appears
to cause such decreases in adipocyte insulin signaling elements as
well as in the other pathways shown in Figure 2, which is a major
paradigm in the field (Table 1) [for reviews, see [9,124,138,139]. In
any case, the mechanisms of adipocyte insulin resistance that are at
play early in obesity induction, whatever they are, may continue to be
active at later times. Several other considerations indicate that sites
downstream of Akt activation and AS160 phosphorylation are signifi-
cant drivers of insulin resistance of adipocyte glucose uptake,
including the very small fraction of Akt signaling needed to maximally
stimulate glucose transport and the fact that other signaling pathways
to glucose transport are also resistant in obesity [reviewed in detail in
Ref. [133].
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7.2. GLUT4 translocation and glucose utilization
Adding to the argument that defects downstream of Akt contribute to
adipocyte insulin resistance are strong data showing that the ma-
chinery driving translocation of GLUT4 to the plasma membrane is
impaired [133,140]. Since intricate steps in membrane trafficking that
mediate GLUT4 translocation to the plasma membrane remain un-
known after almost 40 years of research, neither the exact defective
step or steps, nor the signal triggering it in obesity, have yet been
revealed. Many exciting hypotheses have been offered, such as the
reactive oxygen species generated in insulin resistant states, which
has considerable support [133,141], or potentially adipose hypoxia
[142]. Even the cellular site and step or steps in membrane trafficking
stimulated by insulin signaling is not fully resolved, with competing
hypotheses being evaluated [132]. Although insulin action also inhibits
the endocytosis of GLUT4 [143,144], adding to its increase in the
plasma membrane, the effect of obesity and insulin resistant states on
that part of the pathway have not been adequately evaluated. Finally, is
it possible that obesity alters the intrinsic catalytic activity of GLUT4 in
the plasma membrane? This question also has not been fully evalu-
ated. Additional research tools and approaches will likely be needed to
fully resolve these issues regarding GLUT4 translocation and glucose
transport and their responsiveness to both insulin and the disruptions
of obesity.
Another understudied locus of potential high importance in white
adipocyte insulin resistance is the flux of glucose from its cellular
uptake through its glycolytic flow and beyond (Figure 2). It is mostly
assumed in the field that glucose transport across the adipocyte
plasma membrane is strictly rate limiting for glycolysis, which is
supported by studies showing that the overexpression of GLUT4 in
adipocytes in vivo enhances overall glucose metabolism and even
systemic glucose tolerance [114]. Knockout of GLUT4 in adipocytes
has the opposite effect [145]. However, a single fully rate limiting step
would be an unusual situation in complex metabolic pathways since
they are governed by multiple individual rate constants and varying
concentrations of intermediate metabolites under various physiological
conditions. In the case of adipocyte glucose transport, the concen-
tration of intracellular free glucose within the cells in vivo has not been
rigorously measured and defined under various conditions of insulin
sensitivity. Intracellular free glucose would have to be near zero for
transport to be fully rate limiting in lean and obese conditions.
Importantly, increasing glucose phosphorylation capacity by over-
expression of a glucose kinase, such as hexokinase II or glucokinase,
should not increase glucose utilization if this condition is met. How-
ever, this is not the case, as overexpression of glucokinase in adipo-
cytes was able to increase overall glucose uptake into the cells in vivo
in a well-controlled study [146]. Therefore, a central assumption in the
field is in question, and importantly, these data suggest that alterations
in the levels or activities of enzymes in the glycolytic pathway in obesity
may be functional in regulating adipocyte glucose utilization.
Adipocyte hexokinase II is subject to inhibition by glucose 6-phosphate,
further complicating the potential major role of metabolic enzymes in
regulating glucose utilization. Additionally, enzymes in the glycolytic
pathway lead to glycerol 3-phosphate production, the substrate for
fatty acid esterification, reinforcing the potential importance of changes
in expression of glycolytic enzymes in adipose function. Moreover,
obesity in humans and rodents significantly decreases the expression
of enzymes in the pathway of glucose conversion to fatty acid (de novo
lipogenesis), which can lead to changes in the NADPH redox state that
affect glucose metabolism in the pentose shunt. Taken together, these
results strongly suggest that beyond defective adipocyte GLUT4
translocation in obesity, attenuated glucose metabolism as well as
biosynthesis, esterification, and sequestration of fatty acids are key
aspects of adipocyte insulin resistance. These considerations also
raise the interesting unanswered question of whether such changes in
glucose utilization in obesity are mechanistically connected to the
expression and secretion of adipokines from adipocytes.
7.3. Adipocyte gene expression in obesity
The previously described effects of obesity to attenuate insulin
signaling elements, GLUT4 translocation machinery, and glucose
metabolism may be due to allosteric or covalent modifications of the
proteins involved in these processes. These concepts have been
studied and reviewed in the context of protein kinase-mediated effects
in insulin resistant states [8,125,139]. It seems likely, however, that
much of the insulin resistance in adipocytes in long-term obesity in
humans and rodent model systems is initially driven by the result of
transcriptional regulation of many of the gene products illustrated in
Figure 2 as well as others not listed [82,83,147e152]. Many genes
that are normally responsive to PPARg, the major regulator of adipo-
cyte differentiation and function [152], are attenuated in the expression
of obesity in mice. Recently, important findings have demonstrated that
PPARg-responsive gene promoter regions that are normally occupied
by this transcription factor show decreased occupancy under HFD,
obese conditions [90]. Other examples of adipocyte transcription
factors as targets of obesity are decreases in expression and/or ac-
tivities of CHREBP [86,114,146] and FOXO1 [147,153,154], which
control many genes in the adipocyte pathways as shown in Figure 2.
Similarly, transcriptional regulators such as HDAC3 may be targets of
obesity [149,155]. Taken together, these and other transcription fac-
tors in adipocytes that are targets of disruption in obesity likely play
major roles in defining the expression changes in key proteins that
regulate insulin signaling, GLUT4 translocation, and glucose meta-
bolism. The mechanisms by which obesity decreases the expressions
or activities of such adipocyte transcription factors are poorly under-
stood, and this question is fertile for further investigation.
Collectively, the data from thousands of studies on insulin action and
resistance in white adipocytes indicate that multiple sites in the
pathways of Figure 2 are targets of disruption in obesity in humans and
rodent model systems. Decreased expression of GLUT4 itself and its
ability to respond to insulin via translocation to the cell surface
membrane likely both contribute to adipocyte insulin resistance, at
least in long-term obesity, but decreased expression or activities of
enzymes in glucose metabolism, especially conversion to lipids, also
likely participate in a major way. Probably the most marked example of
the latter is the nearly complete downregulation of adipocyte de novo
lipogenesis that occurs upon HFD feeding [5,135,156]. Much of this
effect is attributed to decreased transcription and expression of ACLY
(ATP citrate lyase), ACC1 (acetyl CoA carboxylase), and FASN (fatty acid
synthase) enzymes that catalyze the production of palmitate from
acetyl CoA. The degree to which this attenuated flux in fatty acid
biosynthesis within adipocytes triggers communication to the liver and
skeletal muscle through released free fatty acids, circulating adipo-
kines, or perturbations of the nervous system is under investigation
[18,135,157]. Deleting FASN selectively in adipocytes causes major
changes in systemic metabolism, including increased energy expen-
diture and glucose tolerance [135,158], while adipocyte-selective
ACLY deletion shows only a mild phenotype [159]. These experi-
ments are difficult to interpret in detail at present since the metabolic
intermediates in de novo lipogenesis, acetyl CoA, malonyl CoA, and
palmitate, also act as signaling molecules that mediate protein acet-
ylation [160], malonylation [161], and palmitoylation [162], respec-
tively. Nonetheless, such experimentation shows that downregulated
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adipocyte metabolic enzymes through genetic manipulation has a
profound influence on liver and skeletal muscle functions.
Altogether, the most reasonable conclusion from the aforementioned
considerations is that the data largely nullify the idea that a single step
or mechanism alone causes insulin resistance in white adipocytes, as
defined by resistance to the action of insulin to increase glucose uti-
lization in these cells. Rather, a multitude of adipocyte-specific tran-
scriptional effects and protein modifications are elicited in obesity that
together contribute to the consistent dampening of insulin action on
adipocyte glucose metabolism. Much more work needs to be done on
adipose tissue metabolism in vivo to be able to extrapolate data from
experiments performed in vitro. In particular, there is an urgent need
for more detailed metabolic flux measurements in adipocytes in vivo to
define the contributions to overall insulin responsiveness of metabolic
pathways.
8. BROWN/BEIGE ADIPOCYTE GLUCOSE DISPOSAL IN OBESITY
8.1. Relationship of BAT/beige thermogenesis to systemic glucose
homeostasis
Initially, thermogenic multilocular brown adipocytes were distinguished
from beige adipocytes in mice based on the location of the former in
BAT depots vs the latter in WAT depots mixed with white adipocytes
[25,39e50,163e165]. It should be noted that beige adipocytes are
also equally referred to as “brite” adipocytes in the literature [166].
Differences were also observed in the gene expression profiles be-
tween mouse beige and brown adipocytes [165]. The discovery of
thermogenic adipocytes in humans within depots of white adipocytes
and subsequent characterizations initially suggested they may be more
like beige adipocytes [167e170]. However, more recent findings
indicate that mouse and human BAT, as defined by its presence in the
interscapular location of mice and the supraclavicular location of
humans, are similarly characterized by high levels of UCP1 and ther-
mogenic proteins [171]. In contrast, mouse beige adipocytes are
somewhat less thermogenic, even when sympathetic activity within
adipose tissue is decreased under “humanized” conditions of ther-
moneutral temperatures [171]. Taken together, these new findings
indicate that human and mouse brown adipocytes may elicit even
stronger systemic effects compared to mouse beige adipocytes.
Nonetheless, thermogenic beige adipocytes are associated with
enhanced glucose tolerance in mice [42] and rats [51] and share newly
described mechanisms for this function with BAT [172,173].
Many studies show an association of UCP1-containing thermogenic
beige/BAT with lean and glucose tolerance phenotypes in mice and
humans. These include BAT transplantation studies in mice that
demonstrate significant enhancement of glucose tolerance [174,175].
Obese, glucose-intolerant, or diabetic humans on average display less
mass of brown/beige adipocytes than lean individuals as well as less
18F-labeled fluorodeoxyglucose uptake into BAT [170]. Conversely,
cold exposure in human subjects causes increased abundance and
activity of brown/beige adipocytes and increased glucose tolerance
and insulin sensitivity [176]. There is also evidence that a glucose-
responsive thermogenic biorhythm in BAT is associated with sys-
temic glycemic control in humans [177]. UCP1 expression regulates
insulin-dependent glucose uptake in human adipocytes [178], sug-
gesting along with other data that perhaps the thermogenic activity of
BAT may directly influence glucose disposal into BAT in vivo [52,179].
However, mice are not optimal models for human physiology in this
regard since HFD in mice can be accompanied by increases in WAT
UCP1 rather than decreases, presumably as a compensation mecha-
nism [180]. Nonetheless, chronic administration of b3 adrenergic
agonist CL316243 to mice, which activates the lipolytic and thermo-
genic pathways in brown/beige adipocytes, enhances UCP1 abun-
dance in WAT and BAT while increasing glucose tolerance [180,181].
Initial studies on deletion of UCP1 in mice showed a paradoxical
resistance to HFD-induced obesity [182], likely due to compensatory
mechanisms of thermogenesis in other tissues. Thus, UCP1 knockout
mice do show increased obesity on HFD with age [183] and when
housed at thermoneutrality [184]. Subsequent work confirmed the
effects of UCP1 on the propensity to become obese even in the obesity
resistant 129S mouse strain [185]. Furthermore, UCP1 expression is
associated with beneficial effects on glucose tolerance in rats [51], and
in female mice it appears independent of weight [186,187]. Other
mechanisms of thermogenesis in BAT such as creatine recycling also
contribute to both thermogenesis and resistance to HFD-induced
obesity [188]. Taken together, these findings indicate that there are
favorable effects associated with UCP1-expressing thermogenic adi-
pocytes on glucose tolerance in rodents and humans.
8.2. GLUT1 and GLUT4 translocation in BAT
While both white and brown adipocytes share the feature of secreting
factors that act as hormones to affect liver and skeletal muscle
metabolism, BAT differs fundamentally from WAT in its ability to
directly take up large quantities of glucose [52]. Indeed, BAT trans-
plantation in mice is associated with increased glucose uptake in BAT
but not muscle as it improves glucose tolerance [174,175]. Glucose
uptake and glycolysis appear to be pathways in driving thermogenesis
in mice [189,190], along with fatty acids [191e200]. This may also be
the case in human subjects subjected to the cold, as cold exposure
also increases BAT glucose uptake based on PET imaging [52,178].
Mechanistically, BAT also differs substantially in the pathways of
glucose uptake and metabolism compared to WAT (Figure 3). The
canonical insulin-sensitive GLUT4 translocation pathway operates in
BAT, but in the context of a more active GLUT1 translocation pathway.
Silencing of GLUT4 and GLUT1 in brown adipocytes in culture shows
that both contribute significantly to overall glucose uptake [190], as
opposed to white adipocytes, which have little GLUT1 in vivo. However,
GLUT1-mediated glucose uptake and utilization in BAT is highly
responsive to b-adrenergic regulation, and its ability to lower blood
glucose appears dependent on catecholamine stimulation [201] and
probably less so on insulin stimulation. Nonetheless, insulin stimulates
glucose uptake in BAT to a significant extent [202e205]. Interestingly,
even though white to beige conversion increases fatty acid metabolism
[206], loss of lipolysis [193], or de novo lipogenesis [200] in rodents, it
does not impair survival of mice in the cold, suggesting compensation
by increases in other fuel sources including glucose. Thus, elucidating
the signaling pathways that control GLUT1-mediated glucose uptake
and glucose flux through glycolysis, lipid synthesis, and mitochondrial
oxidation is important for understanding the insulin resistant state as it
impacts BAT in rodents.
Early studies showed that glucose uptake was stimulated by GLUT1-
mediated glucose uptake in BAT and enhanced by b-adrenergic
signaling through increased GLUT1 abundance, even as GLUT4
abundance was decreased [207]. More recently, it was revealed that
GLUT1 translocation from intracellular membranes to the plasma
membrane is a major mode of increased glucose uptake in BAT [208].
As depicted in Figure 3, translocation of GLUT1 to the plasma mem-
brane in brown adipocytes is mediated by the cAMP pathway, but there
is some disagreement about whether PKA [52,208,209] vs Epac1
[210] is the downstream mediator of cAMP on GLUT1 translocation.
There is consensus, however, that downstream of cAMP signaling is
the requirement that the mTORC2 complex be functional [52,208e
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213], an unexpected finding since mTORC2 is also known as an in-
termediate in insulin signaling to Akt (Figure 3). How mTORC2 engages
the GLUT1 trafficking machinery is under investigation, as is the
question of whether Akt is also involved [210]. Experiments have been
reported that show that regulation of Akt2 expression modifies GLUT1-
mediated hexose uptake [210], while other research indicated that Akt
inhibition does not reduce responsiveness of GLUT1 to catecholamine
[208].
Altogether, these studies provide support for the hypothesis that
mTORC2 functions in a novel mode to promote GLUT1 translocation in
brown adipose cells in response to the cAMP/mTORC2 pathway. Cold
exposure markedly stimulates this pathway through activation of
sympathetic nerve fibers within BAT, while the administration of b3-
adrenergic agonist to mice mimics this effect in part through
enhancing the expression of the Dio2 enzyme that produces thermo-
genic T3 from T4 thyroid hormone [214]. Thus, while insulin and
catecholamines are often thought of as antagonistic hormones, cate-
cholamines can paradoxically enhance “apparent” insulin sensitivity.
This may in part be through increased glucose uptake into BAT at
temperatures below thermoneutrality. Moreover, it has been revealed
that adrenergic signaling can cause browning and UCP1 upregulation
in WAT through activation of an mTORC1-dependent mechanism
[215], which is also an insulin-responsive pathway. This is an exciting
area of investigation that will in future studies reveal substantial insight
into glucose flux in BAT. The flux through glucose metabolic pathways
in BAT may also modulate the secretion of beneficial batokines,
providing a dual role for control of systemic glucose tolerance by
changes in BAT glucose metabolism. This is an active area of inves-
tigation that is likely to yield interesting results.
That GLUT1-regulated glucose flux in BAT in response to sympathetic
nerve activation may contribute directly to systemic glucose disposal
raises an important question: Is it a target of disruption in obesity?
While it appears that overall BAT glucose uptake is diminished in
obesity in mice and humans [52,170,216], the detailed analysis of
sites in the pathways of GLUT1 function that are affected has not been
defined. It should be noted that obese mice also display significantly
decreased BAT Akt phosphorylation in response to injected insulin
compared to lean mice [217], indicating that insulin signaling defects
are present as well. Since it is possible that BAT glucose uptake
directly contributes to systemic glucose disposal through GLUT1
regulation, at least in mice under cold stress conditions, the evidence
suggests that obesity disrupts this mode of BAT contribution to sys-
temic glucose tolerance. However, neither these nor more recent
studies have differentiated GLUT1-mediated vs GLUT4-mediated
glucose uptake in BAT in obesity using gene knockout mice. Nor
have there been definitive studies defining the relationship in obesity
between defects in insulin signaling elements and decreased glucose
uptake in BAT. It will be important for future studies to define which
sites in the pathways of BAT glucose uptake and utilization are the
most important in contributing to systemic insulin sensitivity.
Figure 3: Mechanisms whereby brown and beige adipocytes take up and utilize glucose to influence whole body insulin sensitivity and glucose tolerance. BAT and
beige adipocytes are extremely active in taking up glucose, which may contribute significantly to systemic glucose disposal, at least during cold exposure. Left, insulin signaling to
GLUT4: Insulin signaling through Akt to stimulate GLUT4 translocation to the plasma membrane operates as in WAT and BAT, but appears to contribute less to overall glucose
uptake in BAT. Obesity does attenuate this pathway in BAT as it does in WAT. Middle, norepinephrine (NE) signaling to GLUT1: Upon stimulation of sympathetic innervation in BAT or
WAT, brown and beige adipocytes activate a novel mTORC2-dependent pathway to cause GLUT1 trafficking to the plasma membrane. This significantly stimulates glucose uptake
while also activating lipolysis and lipoprotein-based triglyceride hydrolysis to provide fatty acid substrates for uncoupled respiration through UCP1 upregulation. Surprisingly, the
mTORC1 complex was found to mediate the expression of UCP1. Right, glucose uptake for oxidation: Glucose uptake in BAT and beige adipocytes is both oxidized and converted to
fatty acids by upregulated de novo lipogenesis enzymes during NE stimulation. The newly synthesized fatty acids are thought to be rapidly oxidized in chronic uncoupled respiration.
The effects of obesity on GLUT1 translocation and glucose utilization in BAT are less well studied, but the limited data available indicate diminished glucose uptake in BAT in
obesity. A key unanswered question is the degree to which altered brown and beige adipocyte metabolites affect the secretion of both beneficial and deleterious batokines that
regulate systemic metabolism and the effects of obesity on such regulation.
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9. CONCLUSIONS AND THERAPEUTIC STRATEGIES
The last few years have brought major breakthroughs in both the
application of new technologies to adipose biology and novel insights
into mechanisms of adipocyte function. The former advances include
single cell [54,55] and single nuclei [56] gene expression analysis as
well as CRISPR-mediated gene editing [218], while the latter include
unexpected molecular mechanisms of brown/beige adipocyte glucose
uptake through cAMP/mTORC2-mediated GLUT1 as opposed to GLUT4
translocation. It will be important to uncover the unknown elements in
brown/beige cells that act in the translocation of GLUT1 to the cell
surface and compare them to those known to be involved in insulin-
sensitive GLUT4 membrane trafficking. It will also be important to
more thoroughly evaluate the actual contribution of BAT glucose disposal
in humans to determine whether some of the rather low estimates
obtained [24,219] are underestimates [170]. The discovery of multiple
subtypes of both adipocytes and their progenitors within individual ad-
ipose depots begs questions about the relative contributions of GLUT1 vs
GLUT4 to glucose uptake and responsiveness to catecholamines and
insulin in the various adipocyte subtypes. Moreover, the specific con-
tributions made by the various classes of adipocytes to adipokine,
batokine, and metabolite [15e17,24e27,96e102,220,221] secretions
and lipid storage and sequestration will be important to elucidate.
Overall, this progress opens new avenues for deeper investigations into
the underlying mechanisms of the regulation of adipose functions that
lead to systemic glucose tolerance and insulin sensitivity.
The general concept that enhancing white adipocyte insulin sensitivity
translates to improvements in hepatic and skeletal muscle insulin
sensitivity as well as systemic glucose tolerance is now firmly
established by many experimental approaches and laboratories
(Table 2). Equally well established is the concept that insulin sensitivity
of adipocytes can be improved by perturbations at many different sites
in the pathways of insulin signaling, glucose utilization, lipid meta-
bolism, adipokine secretion, and transcription control. These concepts
suggest at least two potentially fruitful therapeutic approaches to
exploit this knowledge. First, these considerations reinforce the ur-
gency to develop methods that can selectively direct therapeutic
agents to adipocytes, analogous to the achievement of liver-selective
delivery of small molecules and biologics. Accomplishing this diffi-
cult goal would yield a considerable payoff in terms of therapeutic
development, as research in the field has already identified beneficial
adipocyte targets. Second, brown/beige adipocytes have tremendous
potential as cell therapeutics since they are particularly active in
secreting multiple factors beneficial to distant metabolic tissues.
Methods for expanding human adipocyte progenitors [57,222] and for
genetic manipulation of adipocytes to enhance “browning” prior to
implantation [218] are in development. Future gains in insights into
these “adipocentric” technologies will reinforce adipocytes as central
players in the larger field of regenerative medicine.
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